The Pfizer-BioNTech vaccine becomes the “first” to receive FDA approval.
Its marketing name will be “Comirnaty” (pronounced as koe-mir'na-tee).
On August 23, 2021, the US Food and Drug Administration granted full approval to the COVID-19 Vaccine by Pfizer-BioNTech to prevent COVID-19 in individuals aged above 16 years. Now, it will be marketed as Comirnaty. Nevertheless, the vaccine remains applicable for emergency use (under EUA) in younger individuals aged 12 through 15 years. Plus, the administration of the...